A new research paper in BMC Infectious Diseases identifies a four-point test using easily measurable clinical variables to accurately identify patients at risk of dying from Clostridium difficile (C.

Arlington, Va. — June 27, 2024 — A new study published today in the American Journal of Infection Control (AJIC) describes the outcome of a new approach to testing for Clostridioides difficile (C.

C. diff colitis is inflammation of a person’s colon due to contagious bacteria. Most people with C. diff colitis fully recover, but in rare cases the condition can be life threatening. It is possible ...

Physicians and nurses don’t seem to agree on which risk factors are considered most important when determining whether or not to test patients for Clostridium difficile, according to a study published ...

SALT LAKE CITY--(BUSINESS WIRE)-- Great Basin Corporation, a privately held life sciences company developing sample-to-result molecular diagnostic solutions, today announced it has submitted a 510(k) ...

A vaccine to prevent a sometimes-deadly intestinal illness could be a powerful tool to control the bacteria called Clostridium difficile, or C. diff. Researchers, including some in Columbus, are ...

Please provide your email address to receive an email when new articles are posted on . Saha and colleagues conducted a prospective study of 50 patients (median age, 51 years; 66% female) with CDI at ...

Ten days after Finch Therapeutics let go 20% of its workforce, the winds have changed. The FDA has lifted a clinical hold on the biotech’s donor-derived microbiome drug for Clostridioides difficile, ...

Clostridium difficile, or C. diff— a potentially deadly bacterial infection that’s gained attention due to its treatment by fecal transplants— occurs when the body’s natural balance of gut bacteria ...

Minnie Hatch, 29, from Salt Lake City, had painful stomach cramps, and other symptoms for months before finding out she had Clostridioides difficile, or C. diff. These bacteria can grow out of control ...